share_log

How Much Of Raffles Medical Group Ltd (SGX:BSL) Do Insiders Own?

How Much Of Raffles Medical Group Ltd (SGX:BSL) Do Insiders Own?

內部人士持有萊佛士醫療集團有限公司(SGX:BSL)多少股份?
Simply Wall St ·  2022/05/31 19:51

A look at the shareholders of Raffles Medical Group Ltd (SGX:BSL) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don't tell me what you think, tell me what you have in your portfolio.

看看萊佛士醫療集團有限公司(SGX:BSL)的股東就能知道哪個集團最強大。機構通常會持有較大公司的股票,我們預計內部人士將持有較小公司相當比例的股份。我通常喜歡看到一定程度的內部人持股,即使只是一小部分。正如納西姆·尼古拉斯·塔勒布所説,不要告訴我你的想法,告訴我你的投資組合中有什麼。

Raffles Medical Group isn't enormous, but it's not particularly small either. It has a market capitalization of S$2.2b, which means it would generally expect to see some institutions on the share registry. In the chart below, we can see that institutions own shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about Raffles Medical Group.

萊佛士醫療集團並不龐大,但也不是特別小。它的市值為22億新元,這意味着它通常預計會有一些機構出現在股票登記簿上。在下面的圖表中,我們可以看到機構擁有該公司的股份。讓我們仔細看看不同類型的股東能告訴我們關於萊佛士醫療集團的信息。

See our latest analysis for Raffles Medical Group

查看我們對萊佛士醫療集團的最新分析

SGX:BSL Ownership Breakdown May 31st 2022
新交所:BSL所有權明細2022年5月31日

What Does The Institutional Ownership Tell Us About Raffles Medical Group?

關於萊佛士醫療集團,機構所有權告訴了我們什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構以一個接近當地市場的指數來衡量它們的表現。因此,他們通常更關注那些被納入主要指數的公司。

We can see that Raffles Medical Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Raffles Medical Group's historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到,萊佛士醫療集團確實有機構投資者;他們持有公司很大一部分股票。這意味着為這些機構工作的分析師已經看過了這隻股票,他們喜歡它。但就像其他人一樣,他們也可能錯了。當多家機構持有一隻股票時,它們總是面臨“擁擠交易”的風險。當這樣的交易出錯時,多方可能會競相快速拋售股票。在一家沒有增長曆史的公司,這一風險更高。你可以在下面看到萊佛士醫療集團的歷史收益和收入,但請記住,故事中總是有更多的東西。

SGX:BSL Earnings and Revenue Growth May 31st 2022
新交所:BSL收益和收入增長2022年5月31日

We note that hedge funds don't have a meaningful investment in Raffles Medical Group. Raffles Medical Holdings Pte. Ltd. is currently the largest shareholder, with 39% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 11% and 8.0%, of the shares outstanding, respectively. Choon Yong Loo, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

我們注意到,對衝基金沒有對萊佛士醫療集團進行有意義的投資。萊佛士醫療控股有限公司。株式會社目前是最大股東,持有39%的流通股。與此同時,第二大和第三大股東分別持有11%和8.0%的流通股。作為第二大股東的春永路也恰好持有首席執行官的頭銜。

After doing some more digging, we found that the top 3 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

經過進一步挖掘,我們發現,前3名股東合計控制了公司一半以上的股份,這意味着他們擁有相當大的權力來影響公司的決策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

雖然研究一家公司的機構持股可以增加你的研究價值,但研究分析師的建議以更深入地瞭解一隻股票的預期表現也是一個很好的做法。有很多分析師在追蹤這隻股票,所以他們的預測可能也是值得的。

Insider Ownership Of Raffles Medical Group

萊佛士醫療集團的內部人所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。管理層最終要向董事會負責。然而,經理人擔任執行董事會成員並不少見,尤其是如果他們是創始人或首席執行官的話。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認為內部人持股是一件好事。然而,在某些情況下,這會讓其他股東更難讓董事會對決策負責。

Our information suggests that insiders maintain a significant holding in Raffles Medical Group Ltd. It has a market capitalization of just S$2.2b, and insiders have S$278m worth of shares in their own names. That's quite significant. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

我們的信息顯示,內部人士持有萊佛士醫療集團有限公司的大量股份。該集團的市值僅為22億新元,內部人士以自己的名義持有價值2.78億新元的股票。這是非常重要的。很高興看到這樣的投資水平。你可以在這裏查看這些內部人士最近是否一直在買入。

General Public Ownership

一般公有制

With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Raffles Medical Group. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

擁有24%股權的普通公眾,主要由個人投資者組成,對萊佛士醫療集團有一定程度的影響力。雖然這羣人不一定能發號施令,但它肯定能對公司的運營方式產生真正的影響。

Private Company Ownership

私營公司所有權

It seems that Private Companies own 42%, of the Raffles Medical Group stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

私人公司似乎擁有萊佛士醫療集團42%的股份。私營公司可能是關聯方。有時,內部人士通過持有一傢俬人公司來對上市公司感興趣,而不是以個人身份。雖然很難得出任何大致的中風結論,但值得注意的是,這是一個值得進一步研究的領域。

Next Steps:

接下來的步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我發現看看到底是誰擁有一家公司是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他信息。

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

我總是喜歡找一個收入增長的歷史。你也可以,通過訪問這張免費的歷史收入和收益圖表詳細圖表.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終這就是未來,而不是過去,這將決定這家企業的所有者將做得多好。因此,我們認為,看看這份免費報告是明智的,它顯示了分析師是否預測到了更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數字是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論